肝素钠盐是一高度硫酸化糖胺聚糖,广泛使用的一种可注射抗凝血剂。
Heparin sodium, a sulfated polysaccharide belonging to the family of glycosaminoglycans, has numerous important biological activities associated with its interaction with diverse proteins, used as an anticoagulant.
动物 A (mg/kg) = 动物 B (mg/kg)×动物 B的Km系数/动物 A的Km系数 | |
例如,已知某工具药用于小鼠的剂量为88 mg/kg , 则用于大鼠的剂量换算方法:将88 mg/kg 乘以小鼠的Km系数(3),再除以大鼠的Km系数(6),得到该药物用于大鼠的等效剂量44 mg/kg。
[1] Lever and Page (2002) Novel drug development opportunities for heparin. Nat.Rev.Drug Discov. 1 140. PMID: 12120095.
分子式 C26H42N2NaO37S5+ |
分子量 1157.92 |
CAS号 9041-08-1 |
储存方式 ﹣20 ℃冷藏长期储存。冰袋运输 |
溶剂(常温) |
DMSO <1 mg/mL |
Water 100 mg/mL |
Ethanol <1 mg/mL |
体内溶解度
NCT Number | Conditions | Interventions | Sponsor/Collaborators | Phases | Start Date | Last Updated |
NCT01598883 | Cardiopulmonary Bypass|Altered Heparin Response | Drug: Heparin|Drug: ATryn | Massachusetts General Hospital|rEVO Biologics | Phase 1 | 2012-06-01 | 2016-12-13 |
NCT01229072 | Chronic Renal Failure | Biological: Heparin sodic|Biological: heparin liquemine | Azidus Brasil | Phase 2|Phase 3 | 2008-07-01 | 2010-10-26 |
NCT00894673 | Cardiac Surgery | Biological: Heparin sodium Hipolabor|Biological: Heparin sodium APP | Azidus Brasil | Phase 3 | 2009-07-01 | 2013-02-22 |
NCT01092455 | Renal Dialysis | Drug: Heparin N reduction | Randolph Quinn|Fresenius Medical Care North America | Phase 4 | 2009-12-01 | 2011-08-31 |
NCT00701623 | Burns | Drug: heparin|Drug: heparin|Drug: folder water | Azidus Brasil | Phase 2|Phase 3 | 2008-06-01 | 2010-10-26 |
NCT00894998 | Cardiac Surgery | Biological: heparin sodium - Cristlia|Biological: Heparin sodium APP | Azidus Brasil | Phase 3 | 2009-06-01 | 2013-02-22 |
NCT00894829 | Cardiac Surgery | Biological: heparin sodium - Eurofarma|Biological: heparin sodium - APP | Azidus Brasil | Phase 3 | 2009-06-01 | 2013-02-22 |
NCT00894959 | Cardiac Surgery | Biological: Heparin sodium Blausiegel 1|Biological: Heparin sodium APP | Azidus Brasil | Phase 3 | 2009-07-01 | 2013-02-22 |
NCT01352039 | Hip Fracture Surgery | Biological: Heparin Sodium - Eurofarma|Biological: Heparin Sodium - APP Pharmaceuticals | Eurofarma Laboratorios S.A. | Phase 3 | 2011-10-01 | 2012-10-15 |
NCT00828776 | Chronic Renal Failure | Biological: Heparin sodic - Cristlia|Biological: heparin - Liquemine (Roche) | Azidus Brasil | Phase 2|Phase 3 | 2007-09-01 | 2009-01-23 |
NCT00848796 | Coronary Artery Bypass Grafting | Drug: Heparin Leo and Hepalean | Southlake Regional Health Centre | 2006-09-01 | 2009-02-19 | |
NCT00894985 | Cardiac Surgery | Biological: heparin sodium - blausiegel|Biological: heparin sodium - APP | Azidus Brasil | Phase 3 | 2009-06-01 | 2013-02-22 |
NCT01454869 | Heparin | Drug: standard care|Drug: Heparin | Tehran University of Medical Sciences | Phase 3 | 2012-02-01 | 2012-12-14 |
NCT01346215 | Chronic Renal Failure | Biological: heparin sodium|Biological: heparin sodium | Laboratrio Qumico Farmacutico Bergamo Ltda.|Azidus Brasil | Phase 3 | 2011-10-01 | 2011-04-29 |
NCT01694459 | Stable Angina|Angina, Unstable|Non-ST Elevation (NSTEMI) Myocardial Infarction | Drug: Low-dose heparin|Drug: Standard dose heparin | San Filippo Neri General Hospital|University of Roma La Sapienza | Phase 4 | 2010-01-01 | 2012-09-26 |
NCT02654561 | Sepsis|Disseminated Intravascular Coagulation | Drug: Heparin Sodium|Drug: Saline | China Medical University, China|Peking Union Medical College Hospital|West China Hospital|First Affiliated Hospital, Sun Yat-Sen University|Central South University|The Second Affiliated Hospital of Harbin Medical University|Zhongda Hospital|Zhejiang Hospital|The First Affiliated Hospital of Dalian Medical University|Shengjing Hospital | Phase 3 | 2016-05-01 | 2016-01-12 |
NCT01318811 | Acute Kidney Injury|Acute Renal Failure|Heart Failure | Drug: Dilute unfractionated heparin|Drug: Standard concentration unfractionated heparin | Vanderbilt University | Phase 4 | 2011-03-01 | 2016-05-06 |
NCT01260519 | Diagnostic Coronary Angiography | Drug: Heparin | Prince Sultan Cardiac Center, Adult Cardiology Department. | Phase 3 | 2008-07-01 | 2010-12-14 |
NCT00905216 | Cardiac Surgery | Drug: heparin sodium - Bergamo|Drug: heparin sodium - APP | Azidus Brasil | Phase 3 | 2009-06-01 | 2011-01-27 |
NCT00912483 | Venous Thromboembolism | Biological: heparin sodium - Blausiegel|Biological: Heparin sodium - APP | Azidus Brasil | Phase 3 | 2010-05-01 | 2013-03-27 |
NCT01363193 | Obesity|Morbid Obesity|Venous Thromboembolism|Atrial Fibrillation|Angina|Chest Pain | Drug: Lean Body Weight-based heparin dose | Nazareth Hospital | 2011-07-01 | 2013-05-13 | |
NCT01823393 | Aortic Stenosis, Non-rheumatic | Drug: Heparin|Drug: NaCl | University Hospital, Montpellier | Phase 4 | 2013-01-01 | 2016-11-30 |
注:以上所有数据均来自公开文献,并不保证对所有实验均有效,数据仅供参考。
相关化合物库
使用AMQUAR产品发表文献后请联系我们